Takeaways: Felix’s sleep apnea program, built with MedSleep, creates a virtual front door for one of Canada’s most under‑diagnosed chronic conditions (≈1 in 4 adults at high risk, only ~3%...
Takeaways: Slenyto gives Canadian clinicians a prescription, extended‑release melatonin specifically studied for children and teens (ages 2 to <18) with autism spectrum disorder and/or Smith‑Mageni...
Takeaways: This approval strengthens Lilly’s competitive stance against other GLP-1/GIP agents in the obesity space by adding a disease-specific indication (OSA) that ties directl...
